| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-12 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |